Edition:
United Kingdom

Medical Equipment, Supplies & Distribution

Page 1

Nuvasive To Acquire Safepassage

Tuesday, 12 Dec 2017

Dec 12 (Reuters) - Nuvasive Inc ::NUVASIVE TO ACQUIRE SAFEPASSAGE.NUVASIVE INC - TERMS OF DEAL WERE NOT DISCLOSED..NUVASIVE INC - NUVASIVE EXPECTS TRANSACTION TO BE ACCRETIVE TO COMPANY'S NON-GAAP EARNINGS PER SHARE (EPS) IN 2018 AND BEYOND.NUVASIVE INC - CO ALSO EXPECTS DEAL TO SUPPORT LONGER-TERM TARGETS FOR REVENUE GROWTH AND EXPANSION OF ITS NON-GAAP OPERATING AND EBITDA MARGINS.

Bastide Le Confort Medical To Buy UK Company Baywater Healthcare

Tuesday, 12 Dec 2017

Dec 12 (Reuters) - BASTIDE LE CONFORT MEDICAL SA ::BUYS UK COMPANY BAYWATER HEALTHCARE.TO BUY 100 PERCENT OF COMPANY BAYWATER HEALTHCARE, WHICH WAS HELD BEFORE BY DUKE STREET..

Stryker France MM Holdings Holds 92.19 Percent Of Vexim - Euronext

Monday, 11 Dec 2017

Dec 11 (Reuters) - EURONEXT::STRYKER FRANCE MM HOLDINGS HOLDS 92.19 PERCENT OF SHARE CAPITAL OF VEXIM <<>> FOLLOWING TENDER OFFER.

Entellus Medical Says Deal May Require Co To Pay Stryker A Termination Fee Of $20.5 Mln

Thursday, 7 Dec 2017

Dec 7 (Reuters) - Entellus Medical Inc ::ENTELLUS MEDICAL SAYS DEAL PROVIDES CO MAY BE REQUIRED TO PAY STRYKER TERMINATION FEE OF $20.5 MILLION UNDER CERTAIN CIRCUMSTANCES - SEC FILING.

Entellus Medical Says Deal May Require Co To Pay Stryker A Termination Fee Of $20.5 Mln

Thursday, 7 Dec 2017

Dec 7 (Reuters) - Entellus Medical Inc ::ENTELLUS MEDICAL SAYS DEAL PROVIDES CO MAY BE REQUIRED TO PAY STRYKER TERMINATION FEE OF $20.5 MILLION UNDER CERTAIN CIRCUMSTANCES - SEC FILING.

Stryker to buy Entellus Medical for $24.00/share in cash

Thursday, 7 Dec 2017

Dec 7 (Reuters) - Entellus Medical Inc ::ENTELLUS MEDICAL ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION FOR A PURCHASE PRICE OF $24.00 PER SHARE IN CASH.DEAL FOR EQUITY VALUE OF ABOUT $662 MILLION.‍ENTELLUS BOARD OF DIRECTORS UNANIMOUSLY APPROVED ENTERING INTO AGREEMENT​.

Stryker to buy Entellus Medical for $24.00/share in cash

Thursday, 7 Dec 2017

Dec 7 (Reuters) - Entellus Medical Inc ::ENTELLUS MEDICAL ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION FOR A PURCHASE PRICE OF $24.00 PER SHARE IN CASH.DEAL FOR EQUITY VALUE OF ABOUT $662 MILLION.‍ENTELLUS BOARD OF DIRECTORS UNANIMOUSLY APPROVED ENTERING INTO AGREEMENT​.

Biotage agrees to buy Horizon Technology in the US for $18.4 mln

Wednesday, 6 Dec 2017

Dec 6 (Reuters) - Biotage Ab ::BIOTAGE ACQUIRES HORIZON TECHNOLOGY AND STRENGTHENS ITS POSITION IN ENVIRONMENTAL AND FOOD SAFETY.

Exactech To Pay $25.8 Million To Osteon Holdings on Deal Termination with TPG Capital -SEC Filing

Monday, 4 Dec 2017

Dec 4 (Reuters) - Exactech Inc ::SAYS IF DEAL WITH TPG CAPITAL IS TERMINATED UNDER CERTAIN CIRCUMSTANCES, CO TO PAY OSTEON HOLDINGS TERMINATION FEE EQUAL TO $25.8 MILLION -SEC FILING.

Exactech And TPG Capital Announce Amended Merger Agreement With Increase In Merger Consideration To $49.25 Per Share

Monday, 4 Dec 2017

Dec 4 (Reuters) - Exactech Inc ::EXACTECH AND TPG CAPITAL ANNOUNCE AMENDED MERGER AGREEMENT PROVIDING FOR INCREASE IN MERGER CONSIDERATION TO $49.25 PER SHARE.EXACTECH INC - MERGER WITH TPG CAPITAL NOW VALUED AT $737 MILLION.EXACTECH INC - ‍TPG CAPITAL HAS ALSO INCREASED ITS EQUITY FINANCING COMMITMENT TO $737 MILLION FOR PURPOSES OF CONSUMMATING MERGER​.EXACTECH - BOARD HAS APPROVED AMENDED MERGER AGREEMENT WITH TPG.EXACTECH INC - ‍THERE IS NO FINANCING CONDITION TO CONSUMMATION OF MERGER WITH COMPANY​.EXACTECH - TPG HAS ARRANGED FULLY COMMITTED EQUITY FINANCING FOR DEAL.EXACTECH - THERE IS NO FINANCING CONDITION TO CONSUMMATION OF TPG'S DEAL WITH COMPANY.

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary